Matches in SemOpenAlex for { <https://semopenalex.org/work/W2913463828> ?p ?o ?g. }
- W2913463828 endingPage "1913" @default.
- W2913463828 startingPage "1905" @default.
- W2913463828 abstract "Background & AimsMany patients with pancreatic adenocarcinoma carry germline mutations associated with increased risk of cancer. It is not clear whether patients with intraductal papillary mucinous neoplasms (IPMNs), which are precursors to some pancreatic cancers, also carry these mutations. We assessed the prevalence of germline mutations associated with cancer risk in patients with histologically confirmed IPMN.MethodsWe obtained nontumor tissue samples from 315 patients with surgically resected IPMNs from 1997 through 2017, and we sequenced 94 genes with variants associated with cancer risk. Mutations associated with increased risk of cancer were identified and compared with individuals from the Exome Aggregation Consortium.ResultsWe identified 23 patients with a germline mutation associated with cancer risk (7.3%; 95% confidence interval, 4.9–10.8). Nine patients had a germline mutation associated with pancreatic cancer susceptibility (2.9%; 95% confidence interval, 1.4–5.4). More patients with IPMNs carried germline mutations in ATM (P < .0001), PTCH1 (P < .0001), and SUFU (P < .0001) compared with controls. Patients with IPMNs and germline mutations associated with pancreatic cancer were more like to have concurrent invasive pancreatic carcinoma compared with patients with IPMNs without these mutations (P < .0320).ConclusionsIn sequence analyses of 315 patients with surgically resected IPMNs, we found that almost 3% to carry mutations associated with pancreatic cancer risk. More patients with IPMNs and germline mutations associated with pancreatic cancer had concurrent invasive pancreatic carcinoma compared with patients with IPMNs without these mutations. Genetic analysis of patients with IPMNs might identify those at greatest risk for cancer. Many patients with pancreatic adenocarcinoma carry germline mutations associated with increased risk of cancer. It is not clear whether patients with intraductal papillary mucinous neoplasms (IPMNs), which are precursors to some pancreatic cancers, also carry these mutations. We assessed the prevalence of germline mutations associated with cancer risk in patients with histologically confirmed IPMN. We obtained nontumor tissue samples from 315 patients with surgically resected IPMNs from 1997 through 2017, and we sequenced 94 genes with variants associated with cancer risk. Mutations associated with increased risk of cancer were identified and compared with individuals from the Exome Aggregation Consortium. We identified 23 patients with a germline mutation associated with cancer risk (7.3%; 95% confidence interval, 4.9–10.8). Nine patients had a germline mutation associated with pancreatic cancer susceptibility (2.9%; 95% confidence interval, 1.4–5.4). More patients with IPMNs carried germline mutations in ATM (P < .0001), PTCH1 (P < .0001), and SUFU (P < .0001) compared with controls. Patients with IPMNs and germline mutations associated with pancreatic cancer were more like to have concurrent invasive pancreatic carcinoma compared with patients with IPMNs without these mutations (P < .0320). In sequence analyses of 315 patients with surgically resected IPMNs, we found that almost 3% to carry mutations associated with pancreatic cancer risk. More patients with IPMNs and germline mutations associated with pancreatic cancer had concurrent invasive pancreatic carcinoma compared with patients with IPMNs without these mutations. Genetic analysis of patients with IPMNs might identify those at greatest risk for cancer." @default.
- W2913463828 created "2019-02-21" @default.
- W2913463828 creator A5000195252 @default.
- W2913463828 creator A5001682484 @default.
- W2913463828 creator A5026494798 @default.
- W2913463828 creator A5029218403 @default.
- W2913463828 creator A5030542670 @default.
- W2913463828 creator A5033829154 @default.
- W2913463828 creator A5036648952 @default.
- W2913463828 creator A5038534642 @default.
- W2913463828 creator A5046007917 @default.
- W2913463828 creator A5049406054 @default.
- W2913463828 creator A5051619233 @default.
- W2913463828 creator A5057540279 @default.
- W2913463828 creator A5063236475 @default.
- W2913463828 creator A5067498947 @default.
- W2913463828 creator A5068945817 @default.
- W2913463828 creator A5078198832 @default.
- W2913463828 creator A5086998230 @default.
- W2913463828 creator A5088993431 @default.
- W2913463828 creator A5090286753 @default.
- W2913463828 date "2019-05-01" @default.
- W2913463828 modified "2023-10-02" @default.
- W2913463828 title "Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms" @default.
- W2913463828 cites W1509191294 @default.
- W2913463828 cites W1517007299 @default.
- W2913463828 cites W1844119416 @default.
- W2913463828 cites W1984068087 @default.
- W2913463828 cites W1987313243 @default.
- W2913463828 cites W1996912024 @default.
- W2913463828 cites W2002355858 @default.
- W2913463828 cites W2011330127 @default.
- W2913463828 cites W2016400633 @default.
- W2913463828 cites W2016448153 @default.
- W2913463828 cites W2021341670 @default.
- W2913463828 cites W2022084965 @default.
- W2913463828 cites W2034255342 @default.
- W2913463828 cites W2040375845 @default.
- W2913463828 cites W2044433401 @default.
- W2913463828 cites W2050565528 @default.
- W2913463828 cites W2055276888 @default.
- W2913463828 cites W2067495748 @default.
- W2913463828 cites W2072852911 @default.
- W2913463828 cites W2083670334 @default.
- W2913463828 cites W2096389376 @default.
- W2913463828 cites W2100014692 @default.
- W2913463828 cites W2103441770 @default.
- W2913463828 cites W2104549677 @default.
- W2913463828 cites W2111898090 @default.
- W2913463828 cites W2119180969 @default.
- W2913463828 cites W2135258713 @default.
- W2913463828 cites W2139777089 @default.
- W2913463828 cites W2146542392 @default.
- W2913463828 cites W2147918436 @default.
- W2913463828 cites W2148560417 @default.
- W2913463828 cites W2148748525 @default.
- W2913463828 cites W2156957647 @default.
- W2913463828 cites W2159435688 @default.
- W2913463828 cites W2161479848 @default.
- W2913463828 cites W2161884651 @default.
- W2913463828 cites W2232697670 @default.
- W2913463828 cites W2239828061 @default.
- W2913463828 cites W2256016639 @default.
- W2913463828 cites W2319794291 @default.
- W2913463828 cites W2343819130 @default.
- W2913463828 cites W2500474929 @default.
- W2913463828 cites W2531887049 @default.
- W2913463828 cites W2558715006 @default.
- W2913463828 cites W2570618306 @default.
- W2913463828 cites W2594464065 @default.
- W2913463828 cites W2622499649 @default.
- W2913463828 cites W2736069212 @default.
- W2913463828 cites W2741937391 @default.
- W2913463828 cites W2754737546 @default.
- W2913463828 cites W2772659101 @default.
- W2913463828 cites W2779680805 @default.
- W2913463828 cites W2783439822 @default.
- W2913463828 cites W2785448859 @default.
- W2913463828 cites W2799574682 @default.
- W2913463828 cites W2801701284 @default.
- W2913463828 cites W2801812177 @default.
- W2913463828 cites W2803439891 @default.
- W2913463828 cites W2809494794 @default.
- W2913463828 cites W2888908131 @default.
- W2913463828 cites W4211181525 @default.
- W2913463828 doi "https://doi.org/10.1053/j.gastro.2019.01.254" @default.
- W2913463828 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6475492" @default.
- W2913463828 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30716324" @default.
- W2913463828 hasPublicationYear "2019" @default.
- W2913463828 type Work @default.
- W2913463828 sameAs 2913463828 @default.
- W2913463828 citedByCount "41" @default.
- W2913463828 countsByYear W29134638282019 @default.
- W2913463828 countsByYear W29134638282020 @default.
- W2913463828 countsByYear W29134638282021 @default.
- W2913463828 countsByYear W29134638282022 @default.
- W2913463828 countsByYear W29134638282023 @default.
- W2913463828 crossrefType "journal-article" @default.